721 - Skin Cancer: Drugs (Answered)

Christina Rees
To ask the Secretary of State for Health, what assessment his Department has made of recent research by the Institute of Cancer Research into the effect of a genetically created herpes-based virus as a remedy against forms of skin cancer.

George Freeman

Talimogene laherparepvec (T-Vec) is still undergoing clinical trials and has not yet been licensed for the treatment of malignant melanoma by the regulatory authorities in either the United States or the European Union.

The Department has made no specfic assessment of research findings into its use to treat melanoma.

We take the issue of ensuring rapid access to innovative therapies very seriously, which is why we have launched an Accelerated Access Review to make recommendations to Government later in the year on speeding up access for National Health Service patients to innovative and cost effective new medicines, diagnostics and medical technologies.